Nicotinamide
Results from Dr. Joshua Grill’s Nicotinamide as an Early Alzheimer’s Disease Treatment (NEAT), a phase 2 clinical trial of nicotinamide in early Alzheimer’s, were recently published in Neurology and highlighted in PsyPost, an online psychology news outlet. To read the article published in PsyPost, click here.
